2009
DOI: 10.1128/aem.02874-08
|View full text |Cite
|
Sign up to set email alerts
|

Complete Genome Sequence of the Chemolithoautotrophic Marine Magnetotactic Coccus Strain MC-1

Abstract: The marine bacterium strain MC-1 is a member of the alpha subgroup of the proteobacteria that contains the magnetotactic cocci and was the first member of this group to be cultured axenically. The magnetotactic cocci are not closely related to any other known alphaproteobacteria and are only distantly related to other magnetotactic bacteria. The genome of MC-1 contains an extensive (102 kb) magnetosome island that includes numerous genes that are conserved among all known magnetotactic bacteria, as well as som… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
116
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 101 publications
(121 citation statements)
references
References 121 publications
5
116
0
Order By: Relevance
“…Strain MC-1 has been demonstrated to use the rTCA cycle for carbon fixation, but initially no bona fide ATP citrate lyase could be identified (Williams et al, 2006). However, recently, the genome sequence of MC-1 has been completed, which has led to the suggestion that the genes Mmc13638 and Mmc13639 encode the large (aclA) and small (aclB) subunits of an ATP-dependent citrate lyase (Schubbe et al, 2009). The aclA gene of strain MC-1 contains an inserted portion that prevented its previous identification as an ATP citrate lyase.…”
Section: Autotrophic Carbon Metabolismmentioning
confidence: 99%
“…Strain MC-1 has been demonstrated to use the rTCA cycle for carbon fixation, but initially no bona fide ATP citrate lyase could be identified (Williams et al, 2006). However, recently, the genome sequence of MC-1 has been completed, which has led to the suggestion that the genes Mmc13638 and Mmc13639 encode the large (aclA) and small (aclB) subunits of an ATP-dependent citrate lyase (Schubbe et al, 2009). The aclA gene of strain MC-1 contains an inserted portion that prevented its previous identification as an ATP citrate lyase.…”
Section: Autotrophic Carbon Metabolismmentioning
confidence: 99%
“…Although this is a conservative estimate because the genome of Mcas is not complete, the products of these orthologous genes seem to be common in Nitrospirae and Proteobacteria MTB, and hence some of them may have roles in magnetotaxis or magnetosome formation. It is widely accepted that chemotaxis and motility have important roles in the magnetotactic swimming behaviors of MTB (Matsunaga et al, 2005;Schü bbe et al, 2009), and genes involved in these processes are among the shared orthologous genes identified (Supplementary Table S3). …”
Section: Genomic Comparison With Proteobacteria Mtbmentioning
confidence: 99%
“…In addition to the magnetosome genes, we have compared the draft genome of Mcas with four complete genomes of Proteobacteria MTB strains, including M. magneticum AMB-1 (Matsunaga et al, 2005), M. gryphiswaldense MSR-1 (Wang et al, 2014) and M. marinus MC-1 (Schü bbe et al, 2009) belonging to the Alphaproteobacteria and D. magneticus RS-1 (Nakazawa et al, 2009) Table S3). Although this is a conservative estimate because the genome of Mcas is not complete, the products of these orthologous genes seem to be common in Nitrospirae and Proteobacteria MTB, and hence some of them may have roles in magnetotaxis or magnetosome formation.…”
Section: Genomic Comparison With Proteobacteria Mtbmentioning
confidence: 99%
“…Furthermore, such an approach could also benefit from the fact that bacteria-mediated delivery of nanoparticles and cargo into cells for various applications is already feasible 24 . Besides potential future efforts towards genetically modified carriers 25 based on known genome sequences 26 and the development of better magnetotactic guidance algorithms to increase the therapeutic index further, these initial findings may influence not only specific engineering concepts and medical interventional methods, but also open opportunities for the synthesis of new targeted therapeutic, imaging, and diagnostic vectors while providing further opportunities to enhance the delivery and efficacy of existing nanocarriers.…”
mentioning
confidence: 99%